Approval marks a major milestone in reducing gadolinium exposure while maintaining diagnostic performance, aligning with clinical guidance to use the lowest effective dose MONTREAL, April 17, 2026 ...
TTP’s latest e-book, The Retinal Delivery Bottleneck: Why Today’s Tools Won’t Scale, explores how delivery technologies must ...
Kiora Pharmaceuticals (NASDAQ: KPRX) today announced the publication of the results from its Phase 1 ABACUS-1 study of ...
Kiora Pharmaceuticals (NASDAQ: KPRX) today announced the publication of the results from its Phase 1 ABACUS-1 study of KIO-301 in Nature Medicine. The ...
Vivian Gomez, a Florida cosmetologist, was convicted in the 2023 death of a social media influencer and Kim K look-alike, following an unlicensed cosmetic procedure at a Burlingame hotel. Prosecutors ...
REDWOOD CITY, Calif. - A woman was convicted of delivering a fatal buttocks injection during an unlicensed cosmetic procedure at a Burlingame hotel, prosecutors said. Vivian Gomez, 53, was convicted ...
Kiora Pharmaceuticals (NASDAQ: KPRX) today announced the publication of the results from its Phase 1 ABACUS-1 study of KIO-301 in Nature Medicine.
Patients undergoing intravitreal anti–vascular endothelial growth factor (VEGF) injections favor topical gel or subconjunctival anesthesia, manual lid retraction, and Betadine-soaked cotton tips for ...
Ocular plans to leverage the 505(b)(2) regulatory pathway for new drug approvals which has the potential to shorten the review timeline for AXPAXLI If approved, AXPAXLI could be the first TKI to be ...
Lawsuits involving intravitreal injections seem to be rare despite millions of procedures being done each year. In a review of 60 lawsuits, manufacturers and compounding pharmacies were sued more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results